Sentence examples for manufacture practices from inspiring English sources

For both patients, tissues were bronchoscopically collected from random region of left upper lobe and right upper lobe and transported to GMP (Good Manufacture Practices) level tissue culture facility for SOX9+ BC isolation and expansion (Fig. 7A).

The basic principles of good manufacture practice and guidelines are also provided.

However, in our study, 10% of samples analyzed exceeded the levels proposed as hygienic feed quality limits in DRBC (1 × 104CFU/g; Good Manufacture Practice 2008).

Nunes (2009), who also studied fish feed, showed that 67% feed samples had counts above the proposed limit by Good Manufacture Practice (2008).

In our study, FB1 levels in the fish feed samples did not exceed the permissible limit from animal feed (5 ppm; Good Manufacture Practice 2008).

We have previously reported the generation of a current Good Manufacture Practice (cGMP -compliant inducGMP -compliant stem cell (inducedine for clinical apluripotent.

Here we report a four-step scalable process that is readily transferable to a Good Manufacture Practice (GMP) facility for the production of functional dopaminergic neurons from hESCs for potential clinical uses.

Each package contained 20 g of water-soluble herbal granules that were manufactured at a Good Manufacture Practice standard facility (Tian Jiang Ltd, Jiangyin, China).

First, one-time delivery of 1 2 plasmids that are much easier to produce and more stable than proteins or mRNAs makes our method more attractive or feasible for generation of clinical-grade iPSCs under current good manufacture practice (cGMP) conditions.

With federal funding, the participating firms undertook pilot programs, some of which led to the incorporation of commercial lean manufacturing practices in the manufacture of defense products.

All new PET radiopharmaceuticals, like any other drugs, must be manufactured under current good manufacturing practices as required by the Food and Drug Administration before clinical evaluation (phases I, II, and III) and submission of new drug application.